Inhibition of laryngeal cancer cell invasion and growth with lentiviral-vector delivered short hairpin RNA targeting human MMP-9 gene

Cancer Investigation

Volumn 26, Issue 10, 2008, Pages 984-989

  Sun, Yanan ^a   Liu, Ming ^a   Yang, Baofeng ^a   Lu, Jianguang ^a   Li, Baoxin ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Gene therapy; Laryngeal squamous cell carcinoma; Matrix metalloproteinases 9; RNA interference

Indexed keywords

CYCLINE; GELATINASE B; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; SHORT HAIRPIN RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CONTROLLED STUDY; DOWN REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LARYNX CANCER; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; TUMOR VOLUME; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENETIC VECTORS; HUMANS; LARYNGEAL NEOPLASMS; LENTIVIRUS; MATRIX METALLOPROTEINASE 9; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; RNA INTERFERENCE; RNA, CATALYTIC; TRANSFECTION;

EID: 57749190369     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900802072897     Document Type: Article

References (25)

1. Xie, M.; Sun, Y.; Li, Y. Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases. Laryngoscope 2004, 114, 2243-2248.
2. Hojilla, C.V.; Mohammed, F.F.; Khokha, R. Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development. Br J Cancer 2003, 89, 1817-1821.
3. Zucker, S.; Vacirca J. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev 2004, 23, 101-117.
4. O'Grady, A.; Dunne, C.; O'Kelly, P.; et al. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression. Histopathol 2007, 51, 793-804.
5. Zheng, H.; Takahashi, H.; Murai, Y.; et al. Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. Anticancer Res 2006, 26, 3579-3583.
6. Quaranta, M.; Daniele, A.; Coviello, M.; et al. MMP-2, MMP-9, VEGF and CA 15.3 in breast cancer. Anticancer Res 2007, 27, 3593-3600.
7. Di Nezza, L.A.; Misajon, A.; Zhang, J.; et al. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion. Cancer 2002 Mar 1, 94, 1466-1475.
8. Franchi, A.; Santucci, M.; Masini, E.; et al. Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck. Cancer 2002, 95 1902-1910.
9. Karavasilis, V.; Malamou-Mitsi, V.; Briasoulis, E.; et al. Matrix metalloproteinases in carcinoma of unknown primary. Cancer 2005, 104, 2282-2287.
10. Fire, A.; Xu, S.; Montgomery, M.K.; et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391, 806-811.
11. Chambers, A.F.; Matrisian, L.M. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997, 89, 1260-1270.
12. Egeblad, M.; Werb, Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002, 2, 161-174.
13. Sun, Y.N.; Xie, M.Q.; Liu, M.; et al. Growth suppression of human laryngeal squamous cell carcinoma by adenovirus-mediated tissue factor pathway inhibitor gene 2. Laryngoscope 2006, 116, 596-601.
14. Gu, W.; Putral, L.; Hengst, K.; et al. Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes. Cancer Gene Ther 2006, 13, 1023-1032.
15. Sumimoto, H.; Hirata, K.; Yamagata, S.; et al. Effective inhibition of cell growth and invasion of melanoma by combined suppression of BRAF (V599E) and Skp2 with lentiviral RNAi. Int J Cancer 2006, 118, 472-476.
16. Kunigal, S.; Lakka, S.S.; Gondi, C.S.; et al. RNAi-mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease-9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth. Int J Cancer 2007, 121, 2307-2316.
17. Tummalapalli, P.; Gondi, C.S.; Dinh, D.H.; et al. RNA interference-mediated targeting of urokinase plasminogen activator receptor and matrix metalloproteinase-9 gene expression in the IOMM-lee malignant meningioma cell line inhibits tumor growth, tumor cell invasion and angiogenesis. Int J Oncol 2007, 3, 5-17.
18. Kondraganti, S.; Mohanam, S.; Chintala, S.K.; et al. Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion. Cancer Res. 2000, 60, 6851-6855.
19. Levesque, A.A.; Eastman, A. p53-based cancer therapies: is defective p53 the Achilles heel of the tumor? Carcinogen 2007, 28, 13-20.
20. Xu, J.; Morris, G.F. p53-mediated regulation of proliferating cell nuclear antigen expression in cells exposed to ionizing radiation. Mol Cell Biol 1999, 19, 12-20.
21. Liu, J.; Zhan, M.; Hannay, J.A.; et al. Wild-type p53 inhibits nuclear factor-kappaB-induced matrix metalloproteinase-9 promoter activation: implications for soft tissue sarcoma growth and metastasis. Mol Cancer Res 2006, 4, 803-810.
22. Meyer, E.; Vollmer, J.Y.; Bovey, R.; et al. Matrix metalloproteinases 9 and 10 inhibit protein kinase C-potentiated, p53-mediated apoptosis. Cancer Res 2005, 65, 4261-4272.
23. Yao, J.; Xiong, S.; Klos, K.; et al. Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cells. Oncogene 2001, 20, 8066-8074.
24. Rao, J.S. Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 2003, 3, 489-501.
25. Bergers, G.; Brekken, R.; McMahon. G, et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000, 2, 737-744.